Gastrointestinal Endoscopy
Volume 70, Issue 4 , Pages 635-644, October 2009

An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients

Current affiliations: Departments of Gastroenterology and Hepatology (J.A.D., J.J.V. G.W.F., L.F.), Quantitative Health Sciences (R.L.), and Thoracic Surgery (T.W.R.), Cleveland Clinic, Cleveland, Ohio, USA

Received 16 October 2008; accepted 1 February 2009. published online 26 June 2009.

Cleveland, Ohio, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 DISCLOSURE: The following author received research support for this study from CSA Medical Inc: J. A. Dumot. All other authors disclosed no financial relationships relevant to this publication.

 If you would like to chat with an author of this article, you may contact him at dumotj@ccf.org.

PII: S0016-5107(09)00254-5

doi:10.1016/j.gie.2009.02.006

Gastrointestinal Endoscopy
Volume 70, Issue 4 , Pages 635-644, October 2009

Article Tools

* Image Usage & Resolution